# Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease

> **NCT06328205** · NA · UNKNOWN · sponsor: **Copka Sonpashan** · enrollment: 80 (estimated)

## Conditions studied

- Dysphagia

## Interventions

- **BEHAVIORAL:** Rehabilitation therapy
- **PROCEDURE:** Glossopharyngeal Nerve Block
- **DRUG:** Lidocaine Hydrochloride
- **BEHAVIORAL:** placebo injection

## Key facts

- **NCT ID:** NCT06328205
- **Lead sponsor:** Copka Sonpashan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06328205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06328205, "Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06328205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*